BOBULSKY SUSAN
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to BOBULSKY SUSAN. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ADPT | Chief Commercial Officer, MRD | Sale | 26,023 | $6.98 | $181,641 | Mar 4, 2025 |
| ADPT | Chief Commercial Officer, MRD | Option Exercise | 5,000 | $1.98 | $9,900 | Oct 8, 2024 |
| ADPT | Chief Commercial Officer, MRD | Award / Grant | 132,979 | — | — | Mar 5, 2024 |
| ADPT | SVP, Diagnostics, clonoSEQ | Award / Grant | 9,158 | — | — | Mar 4, 2021 |
| ADPT | SVP, Diagnostics, clonoSEQ | Option Exercise | 25,000 | $1.98 | $49,500 | Dec 10, 2020 |
| ADPT | SVP, Diagnostics, clonoSEQ | Sale | 10,000 | $50.00 | $500,000 | Sep 29, 2020 |